The 6 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 67.00, with a high estimate of 68.00 and a low estimate of 60.00. The median estimate represents a +68.89% increase from the last price of 39.67.
The current consensus among 6 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.42
Reporting Date Mar 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.